Venlafaxine dependence in a patient with a history of alcohol and amineptine misuse.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 18636997.
- Also identified by DOI 10.1111/j.1360-0443.2008.02266.x.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Venlafaxine is an inhibitor of neuronal serotonin and noradrenaline re-uptake and a weak inhibitor of dopamine re-uptake. There was no indication of problems of abuse/dependence during the clinical trials. A 53-year-old client with a history of alcohol and amineptine misuse and a long history of recurrent depression, for which he was prescribed venlafaxine tablets. Over time, he increased the dosage to 50 tablets daily (3750 mg). Large venlafaxine dosages produced amphetamine-like effects, due possibly to the related increase in dopamine turnover. Once hospitalized for detoxification, the patient had a symptomatology which was consistent with a serotonergic discontinuation syndrome. Physicians should be aware that patients with a history of drug and alcohol abuse might develop venlafaxine dependence.
Medical subject headings
- Antidepressive Agents, Second-Generation
- Cyclohexanols
- Depressive Disorder
- Dibenzocycloheptenes
- Substance-Related Disorders